Report Detail
Global Glucagon Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4652135 |
- 05 December, 2025 |
- Global |
- 103 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Glucagon market size was valued at US$ 643 million in 2024 and is forecast to a readjusted size of USD 960 million by 2031 with a CAGR of 6.0% during review period.
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
This report is a detailed and comprehensive analysis for global Glucagon market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Glucagon market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Glucagon market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Glucagon market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Glucagon market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Glucagon
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Glucagon market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Glucagon market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Inject Glucagon
Nasal Glucagon
Market segment by Application
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Major players covered
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glucagon, with price, sales quantity, revenue, and global market share of Glucagon from 2020 to 2025.
Chapter 3, the Glucagon competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Glucagon market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glucagon.
Chapter 14 and 15, to describe Glucagon sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Glucagon Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Inject Glucagon
- 1.3.3 Nasal Glucagon
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Glucagon Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Emergency Kits
- 1.4.3 General Use
- 1.4.4 Diagnostic & Motility
- 1.4.5 Cardiogenic Shock
- 1.4.6 Others
- 1.5 Global Glucagon Market Size & Forecast
- 1.5.1 Global Glucagon Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Glucagon Sales Quantity (2020-2031)
- 1.5.3 Global Glucagon Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Novo Nordisk
- 2.1.1 Novo Nordisk Details
- 2.1.2 Novo Nordisk Major Business
- 2.1.3 Novo Nordisk Glucagon Product and Services
- 2.1.4 Novo Nordisk Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Novo Nordisk Recent Developments/Updates
- 2.2 Eli Lilly
- 2.2.1 Eli Lilly Details
- 2.2.2 Eli Lilly Major Business
- 2.2.3 Eli Lilly Glucagon Product and Services
- 2.2.4 Eli Lilly Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Eli Lilly Recent Developments/Updates
- 2.3 Fresenius Kabi
- 2.3.1 Fresenius Kabi Details
- 2.3.2 Fresenius Kabi Major Business
- 2.3.3 Fresenius Kabi Glucagon Product and Services
- 2.3.4 Fresenius Kabi Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Fresenius Kabi Recent Developments/Updates
- 2.4 Torrent Labs
- 2.4.1 Torrent Labs Details
- 2.4.2 Torrent Labs Major Business
- 2.4.3 Torrent Labs Glucagon Product and Services
- 2.4.4 Torrent Labs Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Torrent Labs Recent Developments/Updates
- 2.5 Taj Pharmaceuticals
- 2.5.1 Taj Pharmaceuticals Details
- 2.5.2 Taj Pharmaceuticals Major Business
- 2.5.3 Taj Pharmaceuticals Glucagon Product and Services
- 2.5.4 Taj Pharmaceuticals Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Taj Pharmaceuticals Recent Developments/Updates
- 2.6 Xeris Pharmaceuticals
- 2.6.1 Xeris Pharmaceuticals Details
- 2.6.2 Xeris Pharmaceuticals Major Business
- 2.6.3 Xeris Pharmaceuticals Glucagon Product and Services
- 2.6.4 Xeris Pharmaceuticals Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Xeris Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Glucagon by Manufacturer
- 3.1 Global Glucagon Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Glucagon Revenue by Manufacturer (2020-2025)
- 3.3 Global Glucagon Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Glucagon by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Glucagon Manufacturer Market Share in 2024
- 3.4.3 Top 6 Glucagon Manufacturer Market Share in 2024
- 3.5 Glucagon Market: Overall Company Footprint Analysis
- 3.5.1 Glucagon Market: Region Footprint
- 3.5.2 Glucagon Market: Company Product Type Footprint
- 3.5.3 Glucagon Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Glucagon Market Size by Region
- 4.1.1 Global Glucagon Sales Quantity by Region (2020-2031)
- 4.1.2 Global Glucagon Consumption Value by Region (2020-2031)
- 4.1.3 Global Glucagon Average Price by Region (2020-2031)
- 4.2 North America Glucagon Consumption Value (2020-2031)
- 4.3 Europe Glucagon Consumption Value (2020-2031)
- 4.4 Asia-Pacific Glucagon Consumption Value (2020-2031)
- 4.5 South America Glucagon Consumption Value (2020-2031)
- 4.6 Middle East & Africa Glucagon Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Glucagon Sales Quantity by Type (2020-2031)
- 5.2 Global Glucagon Consumption Value by Type (2020-2031)
- 5.3 Global Glucagon Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Glucagon Sales Quantity by Application (2020-2031)
- 6.2 Global Glucagon Consumption Value by Application (2020-2031)
- 6.3 Global Glucagon Average Price by Application (2020-2031)
7 North America
- 7.1 North America Glucagon Sales Quantity by Type (2020-2031)
- 7.2 North America Glucagon Sales Quantity by Application (2020-2031)
- 7.3 North America Glucagon Market Size by Country
- 7.3.1 North America Glucagon Sales Quantity by Country (2020-2031)
- 7.3.2 North America Glucagon Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Glucagon Sales Quantity by Type (2020-2031)
- 8.2 Europe Glucagon Sales Quantity by Application (2020-2031)
- 8.3 Europe Glucagon Market Size by Country
- 8.3.1 Europe Glucagon Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Glucagon Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Glucagon Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Glucagon Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Glucagon Market Size by Region
- 9.3.1 Asia-Pacific Glucagon Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Glucagon Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Glucagon Sales Quantity by Type (2020-2031)
- 10.2 South America Glucagon Sales Quantity by Application (2020-2031)
- 10.3 South America Glucagon Market Size by Country
- 10.3.1 South America Glucagon Sales Quantity by Country (2020-2031)
- 10.3.2 South America Glucagon Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Glucagon Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Glucagon Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Glucagon Market Size by Country
- 11.3.1 Middle East & Africa Glucagon Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Glucagon Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Glucagon Market Drivers
- 12.2 Glucagon Market Restraints
- 12.3 Glucagon Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Glucagon and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Glucagon
- 13.3 Glucagon Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Glucagon Typical Distributors
- 14.3 Glucagon Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Glucagon. Industry analysis & Market Report on Glucagon is a syndicated market report, published as Global Glucagon Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Glucagon market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
